Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Expert Opinion on Biological Therapy|March 5, 2026
Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?Lorenza Di Marco, Federica Valerio, Yuri Maculan, et al.
In Vivo (Athens, Greece)|March 1, 2020
Anti-EGFR Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-analysisAlessandro Rizzo, Giorgio Frega, Angela Dalia Ricci, et al.
Future Oncology (London, England)|December 4, 2019
Third- and later-line treatment in advanced or metastatic gastric cancer: a systematic review and meta-analysisAlessandro Rizzo, Veronica Mollica, Angela Dalia Ricci, et al.
Translational Oncology|August 17, 2022
Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicineRiccardo Carloni, Alessandro Rizzo, Angela Dalia Ricci, et al.
Journal of Personalized Medicine|May 28, 2022
The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-AnalysisAlessandro Rizzo, Matteo Santoni, Veronica Mollica, et al.
Cancers|October 26, 2024
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic ImplicationsAngela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, et al.
Medicines (Basel, Switzerland)|September 4, 2020
PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?Angela Dalia Ricci, Alessandro Rizzo, Chiara Bonucci, et al.
Anticancer Research|March 6, 2020
Recurrent Uterine Smooth-Muscle Tumors of Uncertain Malignant Potential (STUMP): State of The ArtAlessandro Rizzo, Angela Dalia Ricci, Maristella Saponara, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 28, 2020
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future ChallengesAlessandro Rizzo, Alessandro Di Federico, Angela Dalia Ricci, et al.
Pageof 9